REQUEST A DEMO
Total
USD $0.00
Search more companies

G.C.R. Med&Dispo S.A.S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: G.C.R. Med&Dispo S.A.S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

G.C.R. Med&Dispo S.A.S is based in Colombia, with the head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on January 16, 2018. There are currently 3 (2025) people employed by G.C.R. Med&Dispo S.A.S. In its most recent financial highlights, the company reported a net sales revenue drop of 98.32% in 2024. A growth of 139.64% was recorded in its total assets. The net profit margin of G.C.R. Med&Dispo S.A.S increased by 11.33% in 2024.

Headquarters
Carrera 81 # 8 B - 25 Piso 1
Bogota D.C.; Bogota D.C; Postal Code: 0620

Contact Details: Purchase the G.C.R. Med&Dispo S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the G.C.R. Med&Dispo S.A.S report to view the information.
Financial Auditors:
Purchase the G.C.R. Med&Dispo S.A.S report to view the information.
Incorporation Date:
January 16, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after G.C.R. Med&Dispo S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-98.32%
Total operating revenue
-98.32%
Operating profit (EBIT)
518.54%
Net Profit (Loss) for the Period
258.94%
Total Assets
139.64%
Total Equity
147.04%
Operating Profit Margin (ROS)
30.09%
Net Profit Margin
11.33%
Return on Equity (ROE)
12.06%
Quick Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?